CLINICAL_TRIALS
trial_result
· 2012-12-26
Clinical Trial Update: A Study Of CP-690,550 In Stable Kidney Transplant Patients [Phase 1]
Summary
Phase 1 study of CP-690,550 (tofacitinib) in stable kidney transplant patients completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Kidney Transplant | Phase 1 | Status: COMPLETED | Results posted: 2012-12-26